Plasmapheresis for rheumatic diseases in the twenty-first century
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 15 (3) , 197-204
- https://doi.org/10.1097/00002281-200305000-00005
Abstract
As is often the case, one cannot give a simple answer to the question: plasmapheresis-take it or leave it? A thorough review of the current data on the possible mechanisms of action, the efficacy, and the safety of plasmapheresis in rheumatic diseases demonstrates that the answer depends on the disease and the patients involved.Keywords
This publication has 77 references indexed in Scilit:
- Synchronised therapy and high‐dose cyclophosphamide in proliferative lupus nephritisJournal of Clinical Apheresis, 2002
- Recognition and management of Kawasaki diseaseCurrent Paediatrics, 1999
- Thrombotic thrombocytopenic purpura: Early and late respondersAmerican Journal of Hematology, 1997
- Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.Annals of the Rheumatic Diseases, 1992
- Plasma Therapy for Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1985
- Case Report Response of Lupus Nephritis to Plasmapheresis without Demonstration of Circulating Immune ComplexesThe Lancet Healthy Longevity, 1982
- Plasmapheresis in childhood dermatomyositisThe Journal of Pediatrics, 1981
- Reversal of Impaired Splenic Function in Patients with Nephritis or Vasculitis (or Both) by Plasma ExchangeNew England Journal of Medicine, 1979
- Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus ErythematosusNew England Journal of Medicine, 1979
- Comparison of the Effect of Plasmapheresis and Penicillamine on the Level of Circulating Rheumatoid FactorAnnals of the Rheumatic Diseases, 1963